Ihe ọghọm nke mgbasa ọbara nke ụbụrụ, ihe na-emerụ ahụ nke toxins na mbelata ụda olu vaskụla na-eduga n'ọdịdị nke akwara ozi akwara, ọrịa obi na ọrịa ndị ọzọ. Iji gbochie mmepe nke hypoxia na ọnwụ nke mkpụrụ ndụ ụbụrụ, a na-enye ndị ọrịa ọgwụ antioxidants, metabolics, antihypoxants, nootropics na ọgwụ neurotropic ndị ọzọ.
Dabere na ọnọdụ ọnya ahụ, na ọgwụgwọ nke ọrịa ischemic na ọrịa akwara, a na-eji ndị ọrụ dịka Mildronate na Mexidol.
General njirimara ọgwụ
Edere Mexidol na Mildronate maka:
- metabolism ka nma;
- mmegharị nke mgbasa ọbara n'ime arịa nke ụbụrụ;
- mụbaa iguzogide nrụgide anụ ahụ na nke ọgụgụ isi.
N'ime ọgwụgwọ nke ọrịa ischemic na ọrịa akwara ozi, a na-eji Mildronate na Mexidol.
Ihe omuma ndi ozo banyere iji ego ndia bu n'ihi usoro ihe omume sitere na ihe ndi ahu no n’oru.
Brọda
Ngwakọta ọrụ nke Mexicoidol bụ succinate ethylmethylhydroxypyridine. Ngwa a bụ ọgwụ sitere na succinic acid, nke na-ejikọ ngwaahịa nke ihe nchekwa akpụkpọ, antioxidant na metabolic stimulator.
Nnu nke succinic acid na-egbochi peroxidation nke abụba abụba, belata mkpa oxygen dị na sel ụbụrụ ma nwekwuo nguzogide hypoxia. Mexidol na-arụ ọrụ ọrụ ike nke mitochondria ma na-eme ka ọkwa nke ihe macroergic ogige dịkwuo ike (ATP, wdg).
Mexidol na - akpali intracellular njikọ nke nucleic acid na mweghachi nke membranes cell, na - eme ka ọzịza glucose.
Ọgwụ ahụ na-akpali njikọ intracellular nke nucleic acid na mweghachi nke membranes, na-eme ka mgbatị glucose ma na-eme ka mgbasa synaptik dị n'etiti akụkụ ụbụrụ. Mmetụta bara uru na usoro Rheological nke ọbara na ọkwa nke lipoproteins dị ala nwere ike belata mpaghara mmebi ahụ na-adịghị mma na ischemia ma gbochie stenosis vaskụla n'ọdịnihu.
Ojiji nke Mexidol maka iwepu ego na - enyere aka ịkpa onye ọrịa ọsọ ọsọ ma belata agụụ maka mmanya.
Ebumnuche ọgwụ a gosipụtara maka ọrịa ndị a:
- encephalopathy nke discirculatory, post-traumatic na usoro ọmụmụ ndị ọzọ, gụnyere wakporo ọgụ na-akụda mmụọ;
- vegetative-vaskụla dystonia, asthenia;
- nsonaazụ nke ọghọm ụbụrụ, TIA, mmerụ ahụ ụbụrụ;
- mmebi nke imherosclerotic etiology (ya na akwukwo omimi);
- IHD (dịka akụkụ nke usoro mmụta zuru oke);
- nsogbu ụjọ na akwara na ọrịa neurosis-dị ka ọrịa;
- ịxụbiga mmanya ókè na ị withdrawalụ ọgwụ na-egbu egbu, iwepụ ihe mgbaàmà na ị alcoholụ mmanya (ya na ihe mgbaàmà nke vatikal na vaskụla na neurosis);
- nchekasị, mgbasi ike anụ ahụ dị ukwuu (ịba ụba nke nrụgide hypoxia na igbochi mmepe nke ọrịa systemic).
Ọgwụ dị n'ụdị mbadamba na ihe ngwọta maka infusion.
Ihe mgbochi megide iji ihe Mexicoidolia bụ:
- uche mmadụ na usoro nke succinic acid;
- nnukwu akụrụ na ọrụ nke imeju;
- lactation
- ime
- afọ ụmụaka.
Mildronate
Ihe na-arụ ọrụ nke Mildronate bụ meldonium. Isi ọrụ nke mejupụtara ya, yana usoro nhazi ya (gamma-butyrobetaine), nke dị na sel niile nke mmadụ, bụ ịmachi njikọta nke carnitine. Site na mbelata nke mmepụta carnitine, ebugharị ebugharị nke ọdụdụ n'ime mkpụrụ ndụ na-ebelata, isi mmalite nke ike maka anụ ahụ (ATP) na-amalite ịmịpụta tumadi n'ihi glucose, oxidation nke chọrọ oxygen obere ma ghara ịhapụ nnukwu ngwaahịa nke nsị na-egbu egbu.
Gbanwe ọdịdị nke usoro metabolic na-ebelata ihe oxygen chọrọ nke anụ ahụ, na-ebelata hypoxia, na-egbochi mmebi nke mkpụrụ ndụ site na ngwaahịa na-egbu egbu nke mmeghachi omume metabolic.
Ihe analog nke gamma-butyrobetaine nwekwara akụrụngwa nke vasodilating (vasodilating), nke na - enyere aka melite mgbasa ọbara, belata ntolite saịtị necrosis n'oge nkụchi obi na ọrịa ọnya afọ. Ntughari ọbara site na mpaghara mpaghara ischemic na-ebelata ohere ọghọm trophic, na-ebelata ike nke ihe mgbu, na-eme ka ntachi obi na ịrụ ọrụ.
Mildronate na-ebelata ihe oxygen chọrọ site na ibelata hypoxia ma na-egbochi mbibi sel.
A na-atụ aro iji meldonium maka mgbaàmà ndọrọ ego: ọgwụ ahụ na-ebelata ihe mgbaàmà nke ịxụbiga mmanya ókè, na-akwụsị nkwarụ arụ ọrụ nke usoro ụjọ ahụ na - eme ka mgbaàmà mmịpụ kwụsịlata na ọgwụgwọ nke ịhoụbiga mmanya ókè.
Ihe ngosi maka ojiji nke Mildronate bu ogwu ndia:
- akwara obi, ọrịa obi, tinyere obi mgbu;
- infarction myocardial;
- mmebi nke akwara na nkụchi obi;
- nsogbu ụbụrụ (ụbụrụ ụbụrụ, ọnọdụ nke ịrịa ụbụrụ);
- thrombosis nke ụdị dị iche iche;
- ọbara ọgbụgba na nku anya na retina, ihe mgbochi nke akwara azụ na akụkụ ya, retinopathy;
- encephalopathy diski, neuropathy na ọnya ọrịa ndị ọzọ, ịba ụba ngwa ngwa na ụdị shuga 2;
- mwepu ọrịa;
- ike ịrụ ọrụ dị ala;
- nchekasị, nnukwu ahụ ike.
Ọtụtụ ọmụmụ na-egosi ịdị irè nke Mildronate na ọgwụgwọ dị omimi nke ọrịa na-egbochi ọrịa na-adịghị ala ala.
Dabere na njiri mara, a na-eji otu ụzọ atọ nke ntọhapụ ọgwụ ahụ:
- okpokoro;
- sirop;
- ihe ngwọta maka parabulbar (intraocular) na nchịkwa intravenous.
Ihe mgbochi na ọgwụgwọ na Mildronate:
- uche mmadụ na akụkụ nke ọgwụ ahụ;
- mgbali intracranial dị elu (ya na etuto ahụ na -eme ka mmiri na-asọ njọ);
- ime
- lactation
- afọ ụmụaka.
Site na ọrịa na akụrụ na akụrụ, a ga-eji usoro nlezianya rụọ ọgwụgwọ.
Tụnyere Mexicoidol na Mildronate
A na-eji Mildronate na Mexidol mee ihe iji gosipụta ụdị ihe a ma nwee otu ụdị antihypoxic, nke na-ekpebi ịdịmma ha na ischemia nke mpaghara ụbụrụ. Agbanyeghị myirịta, ọgwụ ndị a enweghị ihe jikọrọ ha ma dị iche na usoro omume.
Mmekorita
Ọgwụ abụọ ahụ na-ebelata ihe oxygen chọrọ na ụbụrụ na akwara akwara obi site na ịkwụsị mmeghachi omume peroxidation (n'ihe metụtara Mexicoidol) ma ọ bụ igbochi mbufe nke ọdụdụ (n'ihe banyere Mildronate). Nke a ga - enyere gị aka belata mpaghara necrosis na ọnya obi na nkụchi obi, yana iwelie nnabata nke ibu dị arọ.
Improkwalite mgbasa ọbara n'ọbara n'oge ọgwụgwọ na Mexidol ma ọ bụ Mildronate nwere mmetụta bara uru na ndị ọrịa nwere ọrịa strok ma ọ bụ nwee nsogbu mgbapụta.
Mmekọrịta nke ọgwụ na-eme ka ọgwụgwọ nke ọgwụgwọ dịkwuo mma. Site na ọrịa strok ischemic, mgbaàmà nke ọrịa vestibulo-ataxic, arrhythmias, mgbapu azụ na ọrịa ndị ọzọ, Mildronate na Mexidol nwere ike iwere n'otu oge.
Mildronate na Mexidol bụ ndị contraindicated n'oge ime na lactation.
Kedu ihe dị iche
Ihe dị iche n'etiti ọgwụ abụọ ahụ dị na usoro dị iche iche na nkọwapụta nke mkpughe. Mexidol nwere membrane-stabili, nootropic, cerebroprotective, antioxidant na mmetụta anxiolytic na-adịghị ike, na Mildronate nwere mmetụta angio na cardioprotective.
Na usoro ọgwụgwọ Mexidol, ihe omume nke:
- ọnụ kpọrọ nkụ
- ọgbụgbọ
- mmeghachi omume nfụkasị ahụ;
- iro ụra.
Mmetụta ọzọ Mildronate bụ:
- dyspepsia
- mmụba obi;
- mgbanwe nrụgide;
- mgbakasị ahụ.
N'ọnọdụ ndị a na-adịghị ahụkebe, a na-ahụ adịghị ike, mmeghachi omume nfụkasị, na mmụba nke eosinophils.
A na-egbochi ọgwụ abụọ dị na nwata.
Kedu nke dị ọnụ ala
Ọnụ ego nke Mexidol sitere na 274 rubles maka mbadamba 30 (usoro onunu ogwu - 125 mg) yana site na 1423 rubles maka ampoules 20 nke 5 ml (usoro onunu ogwu - 50 mg / ml).
Ọnụahịa nke Mildronate na-amalite site na 255 rubles maka capsules 40 (usoro onunu ogwu - 250 mg) na site na 355 rubles maka ampoules 10 nke 5 ml (usoro onunu ogwu - 100 mg / ml).
N'iburu n'uche usoro ọgwụgwọ a tụrụ aro (400-800 mg / ụbọchị maka Mexidol na 500-1000 mg / ụbọchị maka Mildronate), ọgwụgwọ meldonium nwere ihe ngosi yiri ya ga-efu ọnụ ala.
Kedu nke ka mma: Mexidol ma ọ bụ Mildronate
Mexidol bụ ọgwụ nootropic na antioxidant, nke a na-enyekarị maka nsogbu nke ọbara na-enye akwara ụbụrụ na ọnya anụ ahụ atherosclerotic. Mildronate nwere mmetụta dị ukwuu na usoro metabolic na sel na ala nke usoro obi.
Nhọrọ nke ego bụ prerogative nke dibia bekee (neurologist, cardiologist, narcologist). Mgbe ọ na-ede ọgwụ, ọ na-eburu n'uche ihe ngosipụta na akụkọ banyere onye ọrịa.
Ndi dibia nyocha
Poroshnichenko A.I., akparamaagwa neurologist, Ryazan
Mexidol bụ ọgwụ dị irè ma dị ọnụ ala nke onye nrụpụta ụlọ, nke enyere ya maka ọtụtụ ọrịa akwara ozi. Ndị ọrịa na-anabata ya nke ọma, ọ naghịkwa akpasu ndị mmadụ iwe.
Ọdịmma ọghọm dị na ya bụ ọgwụ pere mpe nke mkpụrụedemede ya (mbadamba). Iji rụpụta nsonaazụ ngwa ngwa, a ga-emerịrị Mexidol ma ọ bụ intramuscularly.
Mayakov A.I., narcologist, Kursk
Mildronate na-ekpochapụ ihe ngosi ndị a na-ahụkarị na asthenic, na-eme ka oge nwughari maka ị alcoụbiga mmanya na-egbu egbu, ma kpochapụ nsogbu ọgba aghara na akwara akwara na-emetụta ọrịa dịka ọrịa shuga. Ọgwụ nwere mmetụta antiarrhythmic dị ala ma belata oge ime ihe ụfọdụ ọgwụ ike.
Mbelata Mildronate bụ mmetụta ndị na-adịghị mma (adịghị ike, nfụkasị, mgbanwe nke ọbara mgbali), n’agbanyeghi, ha dị ụkọ.
N'iburu n'uche usoro a tụrụ aro, ọgwụgwọ meldonium nwere ihe ngosi yiri ya ga-efu ọnụ ala.
Nyocha ndị ọrịa gbasara Mexidol na Mildronate
Ekaterina, 41 afọ, Moscow
Mgbe a wachara ya ahụ n’azụ (nchọpụta ahụ bụ azụmazụ nke oghere ọnya), ihe mgbu pụtara n’ime temple na azụ isi. Aụrụ m ọgwụ mgbu ruo ọtụtụ ụbọchị, aghọrọ m onye dibịa akwara. Dọkịta ahụ tiri usoro ọgwụgwọ iri nke 10 nke Mexidol. N'ụbọchị 4, enwere m mmetụta mbido mbụ, na ụbọchị 6, ihe mgbu wepụrụ kpamkpam.
Mgbe o nwesịrị ọgwụ, ọ chọpụtara na ọ malitere ihi ụra nke ọma, jiri nwayọ nwayọ na mkpokọta nrụgide na esemokwu, ma tinye uche ngwa ngwa na ọrụ. Ahụghị m mmetụta ọ bụla, enwere m afọ ojuju na ọgwụ.
Maria, onye gbara afọ 33, Tomsk
M gbara Mildronate ruo ụbọchị 10 na nkwado nke dọkịta. N’oge gboo, mmetụta adịghị anya, ma mgbe ụzọ ahụ zuru oke nrụgide laghachiri na nkịtị, mkpọtụ dị n’isi, ehighi ura na ike ọgwụgwụ na-apụ n'anya. Ugbu a, etinyekwuru m ike n'ọrụ ma nwee ike iwepụta oge na-eme ihe ndị kachasị amasị m.
Inje bụ usoro na-adịghị mma, mana nsonaazụ ha dị ịtụnanya.
